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A Corrigendum on
Valenced action/inhibition learning in humans is modulated by a genetic variant linked to
dopamine D2 receptor expression
by Richter, A., Guitart-Masip, M., Barman, A., Libeau, C., Behnisch, G., Czerney, S., et al. (2014).
Front. Syst. Neurosci. 8:140. doi: 10.3389/fnsys.2014.00140
We observed some errors that occurred during the genotyping of DARPP-32 rs907094. Naming
of CC and TT homozygotes was swapped, and, furthermore, six genotypes were wrongly identified
(three people changed fromCT to CC, two people changed fromCT to TT, and one person changed
from TT to CT). All statistics that included DARPP-32 rs907094 genotype were recomputed. We
have corrected the text in the corresponding text passages of the manuscript accordingly (last para-
graph of the Results Section and Table 2). Importantly, these corrections did not affect our main
findings, the effects attributable to the DRD2 TaqIA polymorphism.
Find below the last paragraph of the Results Section and Table 2 with the corrected statistics
including DARPP-32 rs907094 genotype.
Corrected version of the last paragraph of the Results Section
Because the TaqIA polymorphism is located downstream of the DRD2 gene, the observed geno-
type effects might putatively result from linkage disequilibrium with other DRD2 polymorphisms,
including the C957T.We indeed observed an imbalanced distribution of the C957T polymorphism
(rs6277) among TaqIA A1 carriers vs. A2 homozygotes numerically in the first cohort (χ2 = 4.04,
p = 0.132) and significantly in the second cohort (χ2 = 25.49, p < 0.001). Moreover, the DARPP-
32 polymorphism (rs907094) was unequally distributed in the second cohort only (χ2 = 7.62, p =
0.022). In order to rule out confounding effects, we included the polymorphisms as covariates in an
additional ANCOVA. The same was done for COMT Val108/158Met (rs4680), because the cohorts
Richter et al. D2 receptor and action-valence interaction
Corrected version of Table 2.
TABLE 2 | Demographic data.
A1+ A1−
COHORT 1
Women/Men (n = 87) 17/20 26/24 χ2 = 0.31, p = 0.577
Mean age (n = 87) 24.9 ± 3.6 24.3 ± 2.6 t(85) = 0.83, p = 0.410
Smokers/Nonsmokers (n = 87) 15/22 14/36 χ2 = 1.51, p = 0.220
COMT mm/vm/vv (n = 87) 13/14/10 18/15/17 χ2 = 0.73, p = 0.694
DAT1-VNTR 9+/9− (n = 85) 11/25 15/34 χ2 < 0.01, p = 0.996
C957T CC/CT/TT (n = 87) 11/19/7 8/24/18 χ2 = 4.04, p = 0.132
DARPP-32 CC/CT/TT (n = 87) 4/13/20 3/18/29 χ2 = 0.68, p = 0.714
COHORT 2
Women/Men (n = 95) 13/21 35/26 χ2 = 3.20, p = 0.074
Mean age (n = 95) 25.2 ± 3.3 24.2 ± 2.4 t(93) = 1.58, p = 0.121
Smokers/Nonsmokers (n = 95) 5/29 14/47 χ2 = 0.93, p = 0.335
COMT mm/vm/vv (n = 95) 11/14/9 19/27/15 χ2 = 0.09, p = 0.957
DAT1-VNTR 9+/9− (n = 93) 17/17 32/27 χ2 = 0.16, p = 0.693
C957T CC/CT/TT (n = 95) 15/17/2 3/37/21 χ2 = 25.49, p < 0.001
DARPP-32 CC/CT/TT (n = 95) 3/15/16 0/20/41 χ2 = 7.62, p = 0.022
Gender distribution, age (means± standard deviations), number of smokers and nonsmokers. Allelic distributions for following polymorphisms: COMT Val108/158Met (mm, met homozy-
gotes; vm, val/met heterozygotes; mm, met homozygotes), DAT1-VNTR (9+: carriers of the 9-repeat allele 9/9 and 9/10; 9−: 10-repeat homozygous subjects 10/10), C957T (CC/CT/TT
carriers), and DARPP-32 (CC/CT/TT carriers). A1+, carriers of the A1 allele; A1−, A2 homozygotes.
were stratified with respect to that polymorphism. Importantly,
the fourfold action by valence by time by genotype interaction
for the TaqIA polymorphism remained significant [cohort 1:
F(1, 82) = 4.67, p = 0.034, cohort 2: F(1, 90) = 4.65, p = 0.034],
while there was no effect for C957T (cohort 1: p = 0.484, cohort
2: p = 0.832), DARPP-32 (cohort 1: p = 0.610, cohort 2:
p = 0.235), or COMT Val108/158Met polymorphism (cohort 1:
p = 0.149, cohort 2: p = 0.842).
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